G3 Enrolls 7,500 Participants in Project to Build Detailed 'Omics Map of CVD; Pilot Analysis Underway | GenomeWeb

NEW YORK (GenomeWeb) – Global Genomics Group this week said it has finished enrolling a 7,500-patient cohort on which the company will collect and analyze 22 trillion data points, including omics data, and build a detailed network map of atherosclerotic cardiovascular disease (CVD).

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.